ToeFX receives Health Canada approval for clinical trial

ToeFX will begin clinical trials of its light therapy to treat onychomycosis, a fungal infection of the nail. The company’s technology exhibits unique properties specifically for toenail infection treatment. Onychomycosis is difficult to treat and only one in 4 patients respond to treatment.